OCX - Oncocyte Corp
2.87
0.030 1.045%
Share volume: 63,471
Last Updated: 05-09-2025
Pharmaceutical Products/In Vitro, In Vivo Diagnostic Substances:
-0.04%
PREVIOUS CLOSE
CHG
CHG%
$2.84
0.03
0.01%
Summary score
17%
Profitability
8%
Dept financing
8%
Liquidity
50%
Performance
20%
Sector
Manufacturing
Industry
Pharmaceutical Products/In Vitro, In Vivo Diagnostic Substances
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-46.33%
Return on assets
-24.29%
Return on sales
-29148.62%
Return on invested capital
91.06%
Total debt ratio
35.81%
Debt ratio change over timeo
0%
Current Ratio
4.06%
Quick Ratio
0%
Cash Position Ratio
3.73%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-21.93%
Return on assets
-15.43%
Return on sales
-29148.62%
Return on invested capital
-41.36%
Total debt ratio
27.29%
Debt ratio change over timeo
0%
Current Ratio
4.29%
Quick Ratio
0%
Cash Position Ratio
4.05%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-23%
Return on assets
-12.63%
Return on sales
-5603.5%
Return on invested capital
-23.86%
Total debt ratio
37.6%
Debt ratio change over time
0%
Current Ratio
2.7%
Quick Ratio
0%
Cash Position Ratio
2.45%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | OCX | IDXX | LNTH | QDEL |
|---|---|---|---|---|
| Return on equity | -46.33% | -436.07% | 30.89% | 2.91% |
| Return on assets | -24.29% | 7.33% | 3.57% | 2.85% |
| Return on sales | -29148.62% | 22.12% | 14.33% | 16.24% |
| Return on invested capital | 91.06% | 28.28% | 7.87% | 2.94% |
| Profitability | 25% | 58% | 56% | 31% |
| Total debt ratio | 35.81% | 98.27% | 96.96% | 48.06% |
| Debt ratio change over time | 0% | 0% | 15.51% | 0% |
| Dept financing | 9% | 25% | 50% | 12% |
| Current Ratio | 4.29% | 1.02% | 2.62% | 1.74% |
| Quick Ratio | 0% | 0.7% | 2.14% | 1.27% |
| Cash Position Ratio | 4.05% | 0.15% | 1.36% | 0.46% |
| Liquididy | 50% | 13% | 52% | 60% |
| Short-term ratios | OCX | IDXX | LNTH | QDEL |
|---|---|---|---|---|
| Return on equity | -21.93% | 65.8% | 3.84% | 6.55% |
| Return on assets | -15.43% | 7.82% | 1.58% | 5.3% |
| Return on sales | -29148.62% | 23.49% | 5.83% | 29.42% |
| Return on invested capital | -41.36% | 23.76% | 2.44% | 7.3% |
| Profitability | 0% | 95% | 14% | 52% |
| Total debt ratio | 27.29% | 89.78% | 64.68% | 38.36% |
| Debt ratio change over time | 0% | 0% | 19.55% | 0% |
| Dept financing | 8% | 25% | 43% | 11% |
| Current Ratio | 4.29% | 1.02% | 2.62% | 1.74% |
| Quick Ratio | 0% | 0.7% | 2.14% | 1.27% |
| Cash Position Ratio | 4.05% | 0.15% | 1.36% | 0.46% |
| Liquididy | 50% | 15% | 49% | 28% |
